| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.096 | 0.07 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |